• Xiaodong Qin, Yong Qiu, Zhong He, Rui Yin, Zhen Liu, and Zezhang Zhu.
• From the Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
• Spine. 2022 Apr 15; 47 (8): 624-631.

Study DesignA retrospective study.ObjectiveTo determine in which case one level proximal to last substantially touching vertebra (LSTV-1) could be a valid lowest instrumented vertebra (LIV), in which case distal fusion should extend to last substantially touching vertebra (LSTV), and to identify risk factors for distal adding-on.Summary Of Background DataPosterior thoracic fusion to save more lumbar mobile segments has become the mainstay of operative treatment for adolescent idiopathic scoliosis (AIS) with Lenke 1A/2A curves. Although previous studies have recommended selecting the LSTV as LIV, good outcomes could still be achieved in some cases when LSTV-1 was selected as LIV.MethodsNinety-four patients were included in the study with a minimum of 2-year follow-up after posterior thoracic instrumentation, in which LSTV-1 was selected as LIV. Patients were identified with distal adding-on between first erect radiographs and 2-year follow-up based on previously defined parameters. Factors associated with the incidence of adding-on were analyzed.ResultsThe mean follow-up duration was 37.7 ± 15.8 months. Forty patients (42.6%) with LSTV-1 selected as LIV achieved good outcomes at the last follow-up. Several preoperative risk factors significantly associated with distal adding-on were identified, including lower Risser (P = 0.001), longer thoracic curve length (P = 0.005), larger rotation and deviation of LSTV-1 (P  < 0.001), and preoperative coronal imbalance (P = 0.013).ConclusionSkeletally immature patients with long thoracic curve, preoperative coronal imbalance, large rotation, and deviation of LSTV-1 are at increased risk of distal adding-on when selecting LSTV-1 as LIV. Under this condition, distal fusion level should extend to LSTV; while in other case, LSTV-1 could be a valid LIV.Level of Evidence: 4.Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

19 keywords...

hide…